PubMed · 11346030
Dopamine agonists.
Abstract
Dopamine agonists provide an effective means of treating early, middle, and late stages of Parkinson's disease. This article outlines the advantages and disadvantages of dopamine agonists as compared with levodopa therapy. The features and costs of the four Food and Drug Administration-approved agonists (bromocriptine, pergolide, pramipexole, and ropinirole) and apomorphine, another agonist presently under investigation, are discussed.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
P Tuite, B Ebbitt. 2001. Dopamine agonists.. https://doi.org/10.1055/s-2001-13114. https://pubmed.health/record/pubmed%3A11346030/dopamine-agonists
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.